Molina Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm

Core Viewpoint - Molina Healthcare, Inc. is under investigation for possible securities fraud following a significant decline in its stock price after disappointing financial results and lowered earnings guidance [1][3][4]. Financial Performance - On July 7, 2025, Molina reported preliminary adjusted earnings of approximately $5.50 per share and lowered its full-year 2025 adjusted earnings guidance by over 10% to a range of $21.50 to $22.50 per share [3]. - The finalized second-quarter results on July 23, 2025, showed adjusted earnings per diluted share of $5.48, which missed both analyst consensus estimates and prior company guidance [4]. - The earnings shortfall was attributed to increased medical cost pressures, including higher utilization of behavioral health, pharmacy, and inpatient/outpatient services [4]. Stock Price Impact - Following the July 7 announcement, Molina's stock price fell by $6.97, or approximately 2.9%, closing at $232.61 per share [3]. - After the July 23 disclosure of finalized results, the stock price dropped by $32.03, or approximately 16.8%, closing at $158.22 per share, resulting in further investor losses [5].